# Risk for Donor-Derived Syphilis after Kidney Transplantation, China, 2007–2022

**Authors:** Saifu Yin, Lijuan Wu, Congke Liu, Zihao Jia, Jiapei Wu, Fan Zhang, Xianding Wang, Turun Song, Tao Lin

PMC · DOI: 10.3201/eid3007.240009 · Emerging Infectious Diseases · 2024-07-01

## TL;DR

This study examines the risk of syphilis transmission through kidney transplants in China from 2007 to 2022.

## Contribution

The study identifies factors influencing donor-derived syphilis risk and suggests ceftriaxone may reduce transmission.

## Key findings

- Donor-derived syphilis was rare among kidney transplant recipients.
- Active syphilis in donors may increase transmission risk.
- Recipient treatment with ceftriaxone could reduce the risk.

## Abstract

To evaluate the risk of acquiring syphilis from a donated kidney, we evaluated kidney transplantation pairs from West China Hospital, Sichuan, China, during 2007–2022. Donor-derived syphilis was rare. Risk may be higher if donors have active syphilis and may be reduced if recipients receive ceftriaxone.

## Linked entities

- **Chemicals:** ceftriaxone (PubChem CID 5479530)
- **Diseases:** syphilis (MONDO:0005976)

## Full-text entities

- **Diseases:** Syphilis (MESH:D013587)
- **Chemicals:** ceftriaxone (MESH:D002443)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11210647/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11210647/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC11210647/full.md

---
Source: https://tomesphere.com/paper/PMC11210647